Purpose: Accurate initial staging of differentiated thyroid carcinoma (DTC) is paramount to avoid disease persistence or relapses. Neck ultrasound (US) is the gold-standard examination for lymph node staging; however, it might miss the central compartment ones. [F]FDG PET/CT has been used to characterise unclear or suspicious thyroid nodules and can also identify nodal disease. This study tested the diagnostic efficacy of a combined approach, including digital [F]FDG PET/CT of the cervical region and neck US in DTC staging.

Methods: We retrospectively evaluated consecutive patients treated at our centre with high-risk thyroid who had had a neck US and a neck digital [F]FDG PET/CT before surgery and at least one year of follow-up. Diagnostic parameters, including sensitivity (Se) and accuracy (Acc), were compared across US alone, [F]FDG PET/CT alone, and the combined approach using a patient-based analysis (PBA); Se was also tested employing a lesion analysis (LBA). Clinical and SUV parameters were compared with the histology and the one-year outcome via a logistic regression model.

Results: Eighty-two patients (61 females) were included. At the PBA, the combined approach was superior to US alone regarding Se (44% vs 19%, p < 0.05) and Acc (80% vs 72%, p < 0.05) in the central compartment nodes. At the LBA, the combined approach was superior to either method overall (43%, 37%, and 36% for combined, [F]FDG, and US, respectively, p < 0.01) and to US in the central nodes (25% vs 14%, p < 0.01). SUVratio was an independent predictor of histologically aggressive DTC variants (p = 0.009), central compartment metastases (p = 0.04), and incomplete response at follow-up (p = 0.004).

Conclusions: The combined cervical [F]FDG PET/CT / US approach improves the initial staging and harbours valuable prognostic information for DTC patients.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-025-07169-3DOI Listing

Publication Analysis

Top Keywords

[f]fdg pet/ct
16
combined approach
12
staging differentiated
8
differentiated thyroid
8
thyroid carcinoma
8
neck ultrasound
8
digital [f]fdg
8
[f]fdg
5
pet/ct
5
neck
5

Similar Publications

Radiolabelled fibroblast activation protein inhibitor (FAPI) tracers have the potential to overcome the limitations of 2-deoxy-2-[F]fluoro-D-glucose ([F]FDG) and improve the diagnosis and staging of hepato-pancreato-biliary (HPB) cancers. This study aims to compare the diagnostic performance of radiolabelled FAPI versus [F]FDG PET imaging in HPB cancers. A systematic search of PubMed, Embase, Web of Science and Cochrane Library was performed to identify eligible studies on the diagnostic performance of FAPI PET for primary HPB tumours (hepatocellular carcinoma (HCC), pancreatic cancer (PC) and biliary tract cancer (BTC)) and for liver metastases of gastrointestinal origin.

View Article and Find Full Text PDF

Predicting PD-L1 in Lung Adenocarcinoma Using F-FDG PET/CT Radiomic Features.

Diagnostics (Basel)

February 2025

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Research, Investigation and Evaluation of Radiopharmaceuticals, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd, Beijing 100142, China.

: This study aims to retrospectively analyze the clinical and imaging data of 101 patients with lung adenocarcinoma who underwent [F]FDG PET/CT examination and were pathologically confirmed in the Department of Nuclear Medicine at Peking University Cancer Hospital. This study explores the predictive value and important features of [F]FDG PET/CT radiomics for PD-L1 expression levels in lung adenocarcinoma patients, assisting in screening patients who may benefit from immunotherapy. : 101 patients with histologically confirmed lung adenocarcinoma who received pre-treatment [F] FDG PET/CT were included.

View Article and Find Full Text PDF

. CXCR4 is a chemokine receptor that is frequently overexpressed in invasive breast cancer and plays a major role in tumor proliferation, aggressiveness and metastasis. The aim of this prospective study was to establish the value of CXCR4-directed PET imaging in patients with breast cancer using the novel CXCR4-targeted PET probe Ga-Pentixafor by comparing it with F-FDG PET/CT ( = 40).

View Article and Find Full Text PDF

Novel Clinical PET Tracers in the Pipeline for Melanoma.

Curr Oncol Rep

March 2025

Department of Nuclear Medicine, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.

Purpose: The aim of this review is to provide an overview of novel clinical PET tracers in the pipeline for melanoma. Secondarily, to provide a head-to-head comparison with the current clinical standard used in clinical practice, [F]FDG, if available.

Recent Findings: [F]FDG PET/CT has become important in the clinical setting for melanoma as it serves many purposes, but lacks other important qualities due its nonspecific nature.

View Article and Find Full Text PDF

Purpose: This study aimed to compare the findings of magnetic resonance imaging (MRI) and F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) to differentiate reactive lymphadenitis from nodal lymphoma of the head and neck.

Material And Methods: This study included 138 patients with histopathologically confirmed cervical lymphadenopathy, including 35 patients with reactive lymphadenitis and 103 patients with nodal lymphoma, who had neck MRI ( = 63) and/or F-FDG-PET/CT ( = 123) before biopsy. The quantitative and qualitative MRI results and maximum standardised uptake value (SUV) were retrospectively analysed and compared between the 2 pathologies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!